Great post @butcherano I learnt a lot from your post (and also from OvF's reply)
Please post more often.
One minor point.
"actual eGFR" is a contradiction. eGFR, i.e. the estimated GFR, isn't observed directly; it's estimated from serum creatinine levels, age and sex.
One major point
As you know, ACTION3 has two primary effectiveness endpoints, namely uPCR and eGFR slope (plus a safety endpoint).
I believe that a significant result in either of these at the interim readout will be sufficient to continue the trial.
So your concern about eGFR slope is too early.
But I agree that it's a worry for the second readout.
And I doubt we'll be told any eGFR numbers at the interim readout, just sufficiently effective to continue or not.
- Forums
- ASX - By Stock
- DXB
- Dimerix (ASX: DXB) Discussion Thread
Dimerix (ASX: DXB) Discussion Thread, page-190
-
-
- There are more pages in this discussion • 451 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
51.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $280.6M |
Open | High | Low | Value | Volume |
51.5¢ | 54.5¢ | 51.0¢ | $1.715M | 3.301M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 365433 | 51.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
51.5¢ | 19658 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 348488 | 0.510 |
7 | 159577 | 0.505 |
9 | 326933 | 0.500 |
6 | 141020 | 0.495 |
8 | 79503 | 0.490 |
Price($) | Vol. | No. |
---|---|---|
0.520 | 4807 | 1 |
0.535 | 6099 | 1 |
0.540 | 230559 | 3 |
0.545 | 8075 | 2 |
0.550 | 19750 | 3 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online